Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

PREDECT

PREDECT is listed as a small business research supplier in the Scientist.com network, with 1 site in 1 country and 1 service area.

View PREDECT on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1
Countries 1

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Small business

Pharmacology

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • France Paris 1 site

Source: Scientist.com supplier network (site locations)

About this supplier

In the supplier's own words, as listed in the Scientist.com network.

PREDECT is an IMI-funded partnership between 9 academic, 3 SME (Small and Medium Enterprise) and 7 EU pharmaceutical partners, aiming to develop novel, advanced, complex in vitro and in vivo models for breast, prostate and lung cancers. Three dimensional complex cell cultures, attempting to closely mimic in vivo tumors, will be investigated for their improved potential to validate therapeutic targets, applying molecular pathology and systems biology methods to compare the circuitry of resting and perturbed states. The project is expected to shift paradigms in cell biology as well as...

Show the full description

PREDECT is an IMI-funded partnership between 9 academic, 3 SME (Small and Medium Enterprise) and 7 EU pharmaceutical partners, aiming to develop novel, advanced, complex in vitro and in vivo models for breast, prostate and lung cancers.

Three dimensional complex cell cultures, attempting to closely mimic in vivo tumors, will be investigated for their improved potential to validate therapeutic targets, applying molecular pathology and systems biology methods to compare the circuitry of resting and perturbed states. The project is expected to shift paradigms in cell biology as well as preclinical target validation, permitting greater predictivity of drug efficacy in patient cohorts.

Website
www.predect.eu

Source: Scientist.com supplier network, written by the supplier

Get the PREDECT report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with PREDECT on Scientist.com

For prices, more details, or to contact PREDECT, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.